Cellular Therapy for Treatment of Spinal Cord Injury in Zebrafish Model Publisher Pubmed



Tayanloobeik A¹ ; Rabbani Z² ; Soveyzi F² ; Alavimoghadam S² ; Rezaeitavirani M³ ; Goodarzi P⁴ ; Arjmand B^{2, 5} ; Larijani B⁶ Show Affiliations
Source: Molecular Biology Reports Published:2021

Abstract

Spinal cord injury is a serious problem with a high rate of morbidity and mortality for all persons, especially young people (15–25 years old). Due to the large burden and the costs incurred on the government, finding the best therapeutic approach is necessary. In this respect, treatment strategies based on the disease mechanism can be effective. After the first trauma of spinal cord cascades, cellular events happen one after the other known as secondary trauma. The mechanism of secondary events of spinal cord injury could be helpful for target therapy as trying to stop the secondary trauma. Herein, some medical and surgical therapy has been introduced and cell therapy strategy was considered as a recent method. Actually, cell therapy is defined as the application of different cells including mesenchymal stem cells, embryonic stem cells, induced pluripotent stem cells, and some others to replace or reconstruct the damaged tissues and restore their functions. However, as a newly emerged therapeutic method, cell therapy should be used through various subclinical studies in animal models to assess the efficacy of the treatment under controlled conditions. In this review, the role of Zebrafish as a recommended model has been discussed and combinatory approach as the probably most useful treatment has been suggested. © 2021, The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.